Skip to content

News Archives

 

Immunitor Grant To Pursue Research Using Honibe® Honey Lozenges™ And Immunoxel

Immunitor Grant To Pursue Research Using Honibe® Honey Lozenges™ And Immunoxel
Immunitor, the developer of Immunoxel an immunotherapy treatment utilized for Tuberculosis, has received a $100,000 grant from Grand Challenges Canada - a program seeking breakthrough and affordable innovations that could transform the way disease is treated in the developing world. Immunitor is creating a new treatment for Tuberculosis by using the Honibe pure dried Honey Lozenge as a delivery mechanism.
Scroll To Top